Literature DB >> 31727541

MYO-MRI diagnostic protocols in genetic myopathies.

Jodi Warman Chardon1, Jordi Díaz-Manera2, Giorgio Tasca3, Carsten G Bönnemann4, David Gómez-Andrés5, Arend Heerschap6, Eugenio Mercuri7, Francesco Muntoni8, Anna Pichiecchio9, Enzo Ricci10, Maggie C Walter11, Michael Hanna12, Heinz Jungbluth13, Jasper M Morrow14, Roberto Fernández-Torrón15, Bjarne Udd16, John Vissing17, Tarek Yousry18, Susana Quijano-Roy19, Volker Straub20, Robert Y Carlier21.   

Abstract

Whole-body magnetic resonance imaging has emerged as a useful imaging tool in diagnosing and characterizing the progression of myopathies and muscular dystrophies. Whole-body MRI indications and diagnostic efficacy are becoming better defined with the increasing number of cases, publications and discussions within multidisciplinary working groups. Advanced Whole-body MRI protocols are rapid, lower cost, and well-tolerated by patients. Accurate interpretation of muscle Whole-body MRI requires a detailed knowledge of muscle anatomy and differential pattern of involvement in muscle diseases. With the surge in recently identified novel genetic myopathies, Whole-body MRI will become increasingly useful for phenotypic validation of genetic variants of unknown significance. In addition, Whole-body MRI will be progressively used as a biomarker for disease progression and quantify response to therapy with the emergence of novel disease modifying treatments. This review outlines Whole-body MRI indications and updates refined protocols and provides a comprehensive overview of the diagnostic utility and suggested methodology of Whole-body MRI for pediatric and adult patients with muscle diseases.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Congenital myopathy; Inflammatory myopathy; Inherited myopathy; Limb girdle muscular dystrophy; Magnetic resonance imaging; Whole-body MRI

Mesh:

Year:  2019        PMID: 31727541     DOI: 10.1016/j.nmd.2019.08.011

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

1.  Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI.

Authors:  Hala Abdulhady; Hossam M Sakr; Nermine S Elsayed; Tamer A El-Sobky; Nagia Fahmy; Amr M Saadawy; Heba Elsedfy
Journal:  Acta Myol       Date:  2022-03-31

2.  Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study.

Authors:  Guido Primiano; Tommaso Verdolotti; Gabriella D'Apolito; Andrea Di Paolantonio; Valeria Guglielmino; Angela Romano; Gabriele Lucioli; Marco Luigetti; Serenella Servidei
Journal:  Genes (Basel)       Date:  2021-11-11       Impact factor: 4.096

3.  Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients.

Authors:  Lorena Di Pietro; Flavia Giacalone; Elvira Ragozzino; Valentina Saccone; Federica Tiberio; Marco De Bardi; Mario Picozza; Giovanna Borsellino; Wanda Lattanzi; Enrico Guadagni; Sara Bortolani; Giorgio Tasca; Enzo Ricci; Ornella Parolini
Journal:  Cell Death Dis       Date:  2022-09-16       Impact factor: 9.685

4.  Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials.

Authors:  Matteo Garibaldi; Tommaso Nicoletti; Elisabetta Bucci; Laura Fionda; Luca Leonardi; Stefania Morino; Laura Tufano; Girolamo Alfieri; Antonio Lauletta; Gioia Merlonghi; Alessia Perna; Salvatore Rossi; Enzo Ricci; Jorge Alonso Perez; Tommaso Tartaglione; Antonio Petrucci; Elena Maria Pennisi; Marco Salvetti; Gary Cutter; Jordi Díaz-Manera; Gabriella Silvestri; Giovanni Antonini
Journal:  Eur J Neurol       Date:  2021-12-06       Impact factor: 6.288

5.  Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD.

Authors:  Saskia Lassche; Benno Küsters; Arend Heerschap; Maxime V P Schyns; Coen A C Ottenheijm; Nicol C Voermans; Baziel G M van Engelen
Journal:  J Neuromuscul Dis       Date:  2020
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.